Dusa Pharmaceuticals DUSA reported its Q4 EPS at $0.12, versus the consensus of $0.04. DUSA reported its Q4 revenue at $12 million, versus the consensus of $10.28 million.
DUSA shares gained 7.02% to close at $3.20 yesterday.
Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
